On December 6th, Ministers of Health and representatives of the Beneluxa countries met to discuss the Beneluxa Initiative. Subjects of this exchange on political level were the current state of…
The Beneluxa Initiative aims to ensure sustainable access
to innovative medicine at affordable cost for our patients.
Ministers of Health acknowledge the importance of a HTA on Covid Therapeutics
The information on the Joint HTA assessment of ZYNTEGLO has been updated
ZYNTEGLO betibeglogene autotemcel (shorter name: beti-cel) was jointly assessed as a Beneluxa pilot, which led to a successful publication of this joint effort in July 2021. The pharmacotherapeutic…
Outcome of joint negotiations for Zolgensma
Belgium, Ireland and the Netherlands have reached an agreement on the pricing of Zolgensma, a gene therapy for the treatment of Spinal Muscular Atrophy (SMA). Zolgensma will be reimbursed for two…